| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4935422 | Seizure | 2017 | 4 Pages |
Abstract
ESL was well-tolerated and effective in elderly patients in a real-life setting over 1Â year, with a dose around 800Â mg/day. AE effects improved in most of who switched from CBZ or OXC to ESL
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
A. Gómez-Ibáñez, J.M. Serratosa, E. Guillamón, M. Garcés, B.G. Giráldez, M. Toledo, J. Salas-Puig, F.J. López-González, J. RodrÃguez-Uranga, A. Castillo, J.A. Mauri, J.L. Camacho, E. López-Gomáriz, P. Giner, N. Torres, J. Palau, A. Molins,